Fundraising Fox
🦊/Companies
Sign in

Peptomyc

Barcelona, ES · 4 known investors

Find your way into Peptomyc

Peptomyc is a biotech company developing MYC inhibitors for cancer treatment, based on the Omomyc molecule, and is advancing them through preclinical and clinical trials. It operates in oncology drug development, with its research group linked to the Vall d'Hebron Institute of Oncology in Barcelona, Spain.

BiotechDeep TechHealthtechMedical Devices

Founders & leadership

DM
Dr. Marie-Eve BeaulieuCo-founder
LSLaura Soucek
Laura SoucekinCo-founder & CSO (former CEO)

Investors · 4

Aurora ScienceMilano
Invivo Capital PartnersBarcelona · $2.2M – $4.3M
Alta Life SciencesreportedBarcelona
Asabys PartnersreportedMadrid

In the news

Peptomyc eyes funds for phase II cancer trial - EIT Healtheithealth.eu · Jan 2022Peptomyc - Investorspeptomyc.com · Jan 2022Peptomyc announces new equity financing round led by Aurora Sciencestartupsreal.com · Dec 2020EIT Health-backed cancer therapy firm Peptomyc receives €4.2 million in financing - EIT Healtheithealth.eu · Jul 2019Peptomyc Receives €4.2M To Continue Anti-Cancer Peptide Developmentlabiotech.eu · Sep 2017

Frequently asked questions

What does Peptomyc do?
Peptomyc is a biotech company developing MYC inhibitors for cancer treatment, based on the Omomyc molecule, and is advancing them through preclinical and clinical trials. It operates in oncology drug development, with its research group linked to the Vall d'Hebron Institute of Oncology in Barcelona, Spain.
Who founded Peptomyc?
Peptomyc was founded by Dr. Marie-Eve Beaulieu, Laura Soucek.
Who are Peptomyc's investors?
Peptomyc's investors include Aurora Science, Invivo Capital Partners, Alta Life Sciences, Asabys Partners.
Where is Peptomyc headquartered?
Peptomyc is headquartered in Barcelona, ES.